Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3776
The Honest Company
HNST
$414M
| $181K | ﹤0.01% |
60,109
+14,914
| +33% | +$46.5K |
|
|
CAN
3777
Canaan Creative
CAN
$136M
| $179K | ﹤0.01% |
86,969
-1,000
| -1% | -$2.77K |
|
|
BCOV
3778
DELISTED
Brightcove, Inc.
BCOV
| $179K | ﹤0.01% |
34,222
+32,438
| +1,818% | +$189K |
|
|
THR
3779
DELISTED
Thermon Group Holdings
THR
| $179K | ﹤0.01% |
8,896
+7,492
| +534% | +$139K |
|
3780
Central Garden & Pet Co
CENT
$2.73B
| $178K | ﹤0.01% |
5,944
+2,526
| +74% | +$79.9K |
|
3781
NI Holdings
NODK
$311M
| $178K | ﹤0.01% |
13,392
+1,913
| +17% | +$26.1K |
|
3782
ARS Pharmaceuticals
SPRY
$521M
| $178K | ﹤0.01% |
20,810
+825
| +4% | +$5.35K |
|
|
SEI
3783
Solaris Energy Infrastructure
SEI
$3.19B
| $177K | ﹤0.01% |
17,864
+16,525
| +1,234% | +$181K |
|
|
SOHU
3784
Sohu.com
SOHU
$364M
| $177K | ﹤0.01% |
12,921
+12,910
| +117,364% | +$191K |
|
|
APEN
3785
DELISTED
Apollo Endosurgery, Inc.
APEN
| $177K | ﹤0.01% |
17,762
+16,604
| +1,434% | +$124K |
|
3786
Colliers International
CIGI
$5.11B
| $177K | ﹤0.01% |
+1,922
| New | +$178K |
|
|
DHIL
3787
DELISTED
Diamond Hill
DHIL
| $177K | ﹤0.01% |
955
+830
| +664% | +$147K |
|
|
RYZ
3788
Ryerson Holding Corp
RYZ
$1.43B
| $176K | ﹤0.01% |
5,819
+4,995
| +606% | +$148K |
|
|
CWAN
3789
DELISTED
Clearwater Analytics
CWAN
| $175K | ﹤0.01% |
9,343
+317
| +4% | +$5.49K |
|
3790
Health Catalyst
HCAT
$163M
| $175K | ﹤0.01% |
16,470
+12,054
| +273% | +$116K |
|
|
CCF
3791
DELISTED
Chase Corporation
CCF
| $175K | ﹤0.01% |
2,027
+1,392
| +219% | +$125K |
|
|
BASE
3792
DELISTED
Couchbase
BASE
| $175K | ﹤0.01% |
13,162
+12,039
| +1,072% | +$156K |
|
3793
Ryan Specialty Holdings
RYAN
$5.82B
| $174K | ﹤0.01% |
4,198
-8,745
| -68% | -$358K |
|
|
TIXT
3794
DELISTED
TELUS International
TIXT
| $174K | ﹤0.01% |
8,800
+2,400
| +38% | +$53.1K |
|
3795
Noodles & Co
NDLS
$110M
| $174K | ﹤0.01% |
3,960
+1,138
| +40% | +$49.9K |
|
|
ILPT
3796
Industrial Logistics Properties Trust
ILPT
$575M
| $174K | ﹤0.01% |
53,173
+11,330
| +27% | +$47.2K |
|
|
NIU
3797
Niu Technologies
NIU
$200M
| $174K | ﹤0.01% |
33,245
| – | – |
|
|
KLR
3798
DELISTED
Kaleyra, Inc.
KLR
| $174K | ﹤0.01% |
65,752
+60,588
| +1,173% | +$201K |
|
3799
eGain
EGAN
$188M
| $173K | ﹤0.01% |
19,136
+4,767
| +33% | +$39.2K |
|
3800
Excelerate Energy
EE
$1.24B
| $173K | ﹤0.01% |
6,891
+6,104
| +776% | +$160K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.